Imagen de Portada

Adult-onset Still's disease after ChAdOx1 nCoV-19 vaccine: a possible association

Fuente: Redalyc

Guardado en:

Detalles Bibliográficos
Autor principal:	Laíssa Fiorotti Albertino
Formato:	Artículo científico
Lenguaje:	en
Publicado:	Hospital Universitário da Universidade de São Paulo 2022
Materias:	Medicina COVID Onset Adult 19 Vaccines Still's Disease
Acceso en línea:	Acceder al recurso 1 Acceder al recurso 2 Acceder al recurso 3 Acceder al recurso 4 Acceder al recurso 5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

A study on determining the views of people on the COVID-19 vaccine
por: Tengilimoğlu, Dilaver, et al.
Publicado: (2025)

Effect of COVID 19 vaccination on the CT severity score for SARS CoV2 pneumonia- an experience from the initial wave
por: R. Batra
Publicado: (2023)

Prevalence of parents' non-intention to vaccinate their children and adolescents against COVID-19: a comparative analysis in Colombia and Peru
por: Benites-Zapata, Vicente A., et al.
Publicado: (2022)

Oral antiviral vaccines in aquaculture: Current status, challenges, and future prospects.
por: Rojas-Peña, M, et al.
Publicado: (2026)

Enfermedad de Still del adulto. Revisión de la literatura
por: Ilescas Martínez, Iván
Publicado: (2019)

Prevalence of COVID-19 among healthcare workers before and after vaccination
por: Karina Pinheiro Teixeira dos Reis
Publicado: (2024)

Applications of artificial intelligence and nanotechnology in vaccine development.
por: Bahrami, Yadollah, et al.
Publicado: (2025)

Evaluation of the efficacy of microencapsulatedscaffold against Edwardsiellatardain oral vaccinated Nile tilapia (Oreochromis niloticus).
por: Elumalai, Preetham, et al.
Publicado: (2025)

Transformations in Early Childhood Social Bonds During the COVID-19 Pandemic and the Rise in Autism Diagnoses
por: Pavolink, Jose
Publicado: (2025)

Attaining the 2030 Sustainable Development Goal of Good Health and Well-Being
Publicado: (2023)

Development and evaluation of recombinant multi-epitopes vaccine against nervous necrosis virus.
por: Zhang, Chen, et al.
Publicado: (2025)

Protection of Nile tilapia against Aeromonas hydrophila using a cobalt oxide nanoparticle vaccine containing inactivated whole cell bacteria.
por: Lakshmi, Sreeja, et al.
Publicado: (2025)

Enfermedad de Still del Adulto. Revisión de la Literatura
por: Illescas-Martínez, I.; Hernández- Martínez, Ma. T. & Luis-Reyes, A
Publicado: (2019)

Miopericarditis en enfermedad de Still del adulto. Reporte de un caso.
por: Carmen Eliana Peralta Vargas
Publicado: (2008)

Conhecimento, percepção e adesão ao calendário vacinal em adultos brasileiros: um inquérito online
por: Nicoleti Zamproni, Laura, et al.
Publicado: (2026)

IL-7 enhances the protective efficacy of inactivated grass carp reovirus vaccine as adjuvant in grass carp (Ctenopharyngodon idella).
por: Wang, Shijie, et al.
Publicado: (2026)

Comportamiento de la enfermedad de Still del adulto en el Centro de Reumatología
por: Urbano Solis Cartas
Publicado: (2014)

Protective efficacy of Interferon-γ and β-glucan adjuvanted formalin killed vaccines in Nile tilapia against Edwardsiella tarda infection.
por: Guha, Ritam, et al.
Publicado: (2025)

The roles of the BarA-UvrY two-component system in the virulence of Vibrio harveyi and the efficacy evaluation of mutant strains ΔbarA and ΔuvrY as live-attenuated vaccines.
por: Zhang, Yilin, et al.
Publicado: (2026)

Construction and analysis of the immune effect of subunit vaccines based on the flagellin FlaB and FlaC of Vibrioharveyi.
por: Zhang, Han, et al.
Publicado: (2025)

Enfermedad de Still del adulto
por: Bárbara Lorenzo Suárez Rodríguez
Publicado: (2013)

Management and governance structure of technology transfer megaprojects in emergency contexts: a case study of the megaproject Oxford/AstraZeneca/Fiocruz Covid-19 vaccine
por: Priscila Ferraz Soares
Publicado: (2023)

Enfermedad de Still: padecimiento poco frecuente en paciente de edad poco habitual
por: Arturo Olvera-Acevedo
Publicado: (2020)

Single ChAdOx1 nCoV‐19 dose elicits stronger immune response in previously infected individuals than in SARS‐CoV2 naive persons
por: Fawzi Ebrahim, et al.
Publicado: (2024)

Learning from combination HIV prevention programmes to face COVID-19 emerging pandemic
por: Ricardo Palacios
Publicado: (2020)

Immune and protective effects of recombinant multi-epitopes vaccine against infectious spleen and kidney necrosis virus in pearl gentian grouper (♀Epinephelus fuscoguttatus × ♂Epinephelus lanceolatus).
por: Liu, Xinxin, et al.
Publicado: (2026)

Prevalence and factors associated with the intention of vaccination against COVID-19 in Peru
por: Herrera-Añazco, Percy, et al.
Publicado: (2021)

Manifestación atípica de enfermedad de Still. Reporte de un caso
por: R. Balcázar
Publicado: (2018)

CXCL20a promotes the immune protection of an inactivated vaccine against grass carp reovirus infection in grass carp (Ctenopharyngodon idella).
por: Lu, Yizhong, et al.
Publicado: (2026)

Enhancing farmed fish welfare: Evaluating the effectiveness of plant-based stress mitigating agents as sedatives in sea bass (Dicentrarchus labrax) following intraperitoneal vaccination.
por: Azizi, Sheida, et al.
Publicado: (2025)

Immunopotentiating effects of recombinant TNFα in formalin-killed Streptococcus parauberis vaccine for starry flounder.
por: Sohn, Min-Young, et al.
Publicado: (2026)

A vaccine combining ORF132 and ORF25 expressed by Saccharomyces cerevisiae induces protective immunity in Carassius auratus gibelio against CyHV-2.
por: Liang, Jiahui, et al.
Publicado: (2025)

Safety, immunogenicity, efficacy and effectiveness of inactivated influenza vaccines in healthy pregnant women and children under 5 years: An evidence-based clinical review
por: Bansal, Amit, et al.
Publicado: (2021)

Designing a SAARC-wide Vaccine-sharing Protocol: lessons from COVID-19
por: Diptajyoti Haldar
Publicado: (2025)

The comparative of histopathological study of different organs in vaccination, nonvaccination and exposed to white spot disease in shrimp Litopenaeus vannamei during the study
por: Kakoolaki, S., et al.
Publicado: (2015)

Mucoadhesive chitosan-based nano vaccine as promising immersion vaccine against Edwardsiella tarda challenge in Nile tilapia (Oreochromis niloticus).
por: Nandhakumar, et al.
Publicado: (2025)

An oral multivalent fusion vaccine based on antigenic fragment VP56 and FlaC adjuvant confers effective protection against grass carp reovirus.
por: Tang, Bo, et al.
Publicado: (2026)

A modified IL-7 enhances the immune response to an inactivated GCRV-II vaccine in grass carp (Ctenopharyngodon idella).
por: Wang, Shijie, et al.
Publicado: (2026)

Parents’ perceptions and intention to vaccinate their children under 12 years of age against COVID-19: A cross sectional study in Peru
por: Zamora, Jose Gonzales, et al.
Publicado: (2022)

COVID-19 vaccine hesitancy in a national sample of older Brazilians: the ELSI-COVID Initiative, March 2021
por: Lima-Costa, Maria Fernanda, et al.
Publicado: (2022)